Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation.
about
Chimeric antigen receptor T-cell therapy for solid tumorsPreventing stem cell transplantation-associated viral infections using T-cell therapyAntiviral T-cell therapyToxicity and management in CAR T-cell therapyCombining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphomaAn inducible, ligand-independent receptor activator of NF-κB gene to control osteoclast differentiation from monocytic precursorsMultiple mechanisms determine the sensitivity of human-induced pluripotent stem cells to the inducible caspase-9 safety switchInducible apoptosis as a safety switch for adoptive cell therapyImproving cytomegalovirus-specific T cell reconstitution after haploidentical stem cell transplantationCaspase-9: structure, mechanisms and clinical applicationImmunotherapy in acute leukemiaLong-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgeneAn Inducible Caspase-9 Suicide Gene to Improve the Safety of Therapy Using Human Induced Pluripotent Stem Cells.Immunotherapy of human cancers using gene modified T lymphocytes.The innovative evolution of cancer gene and cellular therapies.Caspase functions in cell death and disease.Improving the safety of cell therapy products by suicide gene transferAdoptive T-cell therapy: adverse events and safety switches.Bortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicity.Genetic modification of T cellsOsteoinductivity of engineered cartilaginous templates devitalized by inducible apoptosisRegulated apoptosis of genetically modified hematopoietic stem and progenitor cells via an inducible caspase-9 suicide gene in rhesus macaques.T cells redirected against CD70 for the immunotherapy of CD70-positive malignanciesAdoptive T cell therapy of cancer.Contributions of gene marking to cell and gene therapies.A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cellsSafeguarding nonhuman primate iPS cells with suicide genes.Personalized cell transfer immunotherapy for B-cell malignancies and solid cancersPiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor.Live and let die: a new suicide gene therapy moves to the clinicInducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantationK562-Derived Whole-Cell Vaccine Enhances Antitumor Responses of CAR-Redirected Virus-Specific Cytotoxic T Lymphocytes In Vivo.Cell fate control gene therapy based on engineered variants of human deoxycytidine kinaseEditorial: Improving the safety of cell therapy products by suicide gene transfer.IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity.Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes.Genetic modification of human T lymphocytes for the treatment of hematologic malignancies.Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies.Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity.Phenotypic and functional attributes of lentivirus-modified CD19-specific human CD8+ central memory T cells manufactured at clinical scale
P2860
Q26750908-AF13B68E-F888-4D9C-BB6B-AE9281F17AB1Q26801365-80E9163B-EDFA-4B4A-AD26-6ED751A956D0Q27028006-E20CC43A-C776-43C2-B3CC-8CEA6A56C2ABQ28075314-0F0F4A32-5E6C-4845-B264-0834ED9ED4CFQ28537688-5B21557A-D443-460C-9737-74AAA8883ADBQ28538066-3D272BB9-026B-45CB-9D1E-1BBF453B1897Q28828176-1A64CE8F-0634-497D-B49F-53F60F38D2F7Q29617710-536E1FC3-2C3D-42B0-9D3B-F2B8EB83E764Q33597783-8586EF43-DDD5-4689-95E5-B690803CE2F3Q33618946-0CA7F372-4934-49A9-B6EE-583D47828F7DQ33731552-AFC447A4-DFC4-4518-AE01-E4EB91485CF2Q33781162-674898C1-17CA-41B3-A067-3716921FD087Q34044130-AE507633-DCB4-4F85-AD62-E6D02E1D09FEQ34188383-0C7F94DD-5CF0-4E9D-BC6C-53C61FF05650Q34325544-EDF4EC93-EA10-401D-8C16-FDD3F3301B55Q34336335-79DD5070-7194-42E1-A533-4CFFA16FC930Q34453846-B3402485-7E54-4E02-BAAE-27CC182D72D5Q34511623-92F273CB-58BE-482B-88A5-A21D3CEF1C30Q34576976-0E03B232-BD7E-4BC0-8C24-A814FE8D8260Q34644876-0489CC46-B46E-477A-831E-7AF65C017908Q34708788-642B4C78-DEF4-4312-A5B4-C45D481CB45CQ34734779-5D4ECA57-A549-47C2-8FE4-523AFB6EE3C9Q34923799-9F1D68A7-C354-4B43-9DD4-D289619167D8Q34977470-D0E9E2CC-F05C-4B54-AEAF-C03342FB7CA4Q35059829-6F16AD90-5586-43BE-88F4-312C875A15D0Q35153765-CC088B88-4119-480C-83AB-B3B336638BFEQ35238279-E5BE93C4-091C-4DD4-BD33-A5B48F112DDFQ35568556-736BC6FE-251F-44FE-BA39-774D2EF98A69Q35623431-D0996DB7-EF67-4062-9EA1-711BC6031F8FQ35665170-1DC4C64F-6AE9-4CA4-938B-7659653C7583Q35784529-571C2122-CE6E-40B8-B349-FB2B82AAE9CCQ35812085-34901B80-292A-445B-BE7E-ED4353A89396Q35939470-F8B77BE4-F38A-47B1-8108-35487D4FF2B0Q35992678-C3560619-9540-45F2-B9F8-25B866A43B8EQ36005345-98319CF3-E187-4C9B-99C9-AAFB4730B952Q36059585-8BC0F435-F340-4880-93D6-E45C30745943Q36366557-FA80761E-D0E3-42F0-B1E2-8F85128EBE45Q36386891-071EA7E1-8125-42E4-A26A-DE442F3E699CQ36429491-D46008C6-49C0-4538-A47A-798050FC49E0Q36475411-A1FB670A-A891-4F83-B517-98D7DB288F88
P2860
Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Inducible caspase 9 suicide ge ...... cal stem cell transplantation.
@en
type
label
Inducible caspase 9 suicide ge ...... cal stem cell transplantation.
@en
prefLabel
Inducible caspase 9 suicide ge ...... cal stem cell transplantation.
@en
P2093
P2860
P1476
Inducible caspase 9 suicide ge ...... cal stem cell transplantation.
@en
P2093
Cliona M Rooney
Gianpietro Dotti
Helen E Heslop
Malcolm K Brenner
Siok-Keen Tey
P2860
P304
P356
10.1016/J.BBMT.2007.04.005
P577
2007-05-29T00:00:00Z